{"id":21121,"date":"2021-06-22T12:25:00","date_gmt":"2021-06-22T12:25:00","guid":{"rendered":"https:\/\/regimbeau.eu\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/"},"modified":"2021-06-22T12:25:00","modified_gmt":"2021-06-22T12:25:00","slug":"ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9","status":"publish","type":"post","link":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/","title":{"rendered":"AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Rapha\u00eblle Gillet and Nicolas Bouquin will discuss the latest decisions regarding antibody patents and in particular the Amgen PCSK9 case at AIS 2021, on June 23rd 2021 at 2PM.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/aiscongress.com\/programme.php\" target=\"_blank\" rel=\"noreferrer noopener\">Check the AIS complete programme<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rapha\u00eblle Gillet and Nicolas B...<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[1067],"tags":[],"class_list":["post-21121","post","type-post","status-publish","format-standard","hentry","category-meetings-ja"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9 - Regimbeau<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9 - Regimbeau\" \/>\n<meta property=\"og:description\" content=\"Rapha\u00eblle Gillet and Nicolas B...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/\" \/>\n<meta property=\"og:site_name\" content=\"Regimbeau\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-22T12:25:00+00:00\" \/>\n<meta name=\"author\" content=\"Rim\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rim\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/ja\\\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/ja\\\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\\\/\"},\"author\":{\"name\":\"Rim\",\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/#\\\/schema\\\/person\\\/cdb9263ae6c8428975c8b64b632a7f40\"},\"headline\":\"AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9\",\"datePublished\":\"2021-06-22T12:25:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/ja\\\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\\\/\"},\"wordCount\":44,\"articleSection\":[\"Meetings\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/ja\\\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\\\/\",\"url\":\"https:\\\/\\\/regimbeau.eu\\\/ja\\\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\\\/\",\"name\":\"AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9 - Regimbeau\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/#website\"},\"datePublished\":\"2021-06-22T12:25:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/#\\\/schema\\\/person\\\/cdb9263ae6c8428975c8b64b632a7f40\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/ja\\\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regimbeau.eu\\\/ja\\\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/ja\\\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/regimbeau.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIS 2021 &#8211; Protecting epitope versus paratope: Case study from Amgen PCSK9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/#website\",\"url\":\"https:\\\/\\\/regimbeau.eu\\\/\",\"name\":\"Regimbeau\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regimbeau.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regimbeau.eu\\\/#\\\/schema\\\/person\\\/cdb9263ae6c8428975c8b64b632a7f40\",\"name\":\"Rim\",\"sameAs\":[\"https:\\\/\\\/www.slotjitu.net\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9 - Regimbeau","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/","og_locale":"ja_JP","og_type":"article","og_title":"AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9 - Regimbeau","og_description":"Rapha\u00eblle Gillet and Nicolas B...","og_url":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/","og_site_name":"Regimbeau","article_published_time":"2021-06-22T12:25:00+00:00","author":"Rim","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"Rim"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/#article","isPartOf":{"@id":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/"},"author":{"name":"Rim","@id":"https:\/\/regimbeau.eu\/#\/schema\/person\/cdb9263ae6c8428975c8b64b632a7f40"},"headline":"AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9","datePublished":"2021-06-22T12:25:00+00:00","mainEntityOfPage":{"@id":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/"},"wordCount":44,"articleSection":["Meetings"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/","url":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/","name":"AIS 2021 - Protecting epitope versus paratope: Case study from Amgen PCSK9 - Regimbeau","isPartOf":{"@id":"https:\/\/regimbeau.eu\/#website"},"datePublished":"2021-06-22T12:25:00+00:00","author":{"@id":"https:\/\/regimbeau.eu\/#\/schema\/person\/cdb9263ae6c8428975c8b64b632a7f40"},"breadcrumb":{"@id":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/regimbeau.eu\/ja\/ais-2021-protecting-epitope-versus-paratope-case-study-from-amgen-pcsk9\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/regimbeau.eu\/"},{"@type":"ListItem","position":2,"name":"AIS 2021 &#8211; Protecting epitope versus paratope: Case study from Amgen PCSK9"}]},{"@type":"WebSite","@id":"https:\/\/regimbeau.eu\/#website","url":"https:\/\/regimbeau.eu\/","name":"Regimbeau","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regimbeau.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/regimbeau.eu\/#\/schema\/person\/cdb9263ae6c8428975c8b64b632a7f40","name":"Rim","sameAs":["https:\/\/www.slotjitu.net"]}]}},"_links":{"self":[{"href":"https:\/\/regimbeau.eu\/ja\/wp-json\/wp\/v2\/posts\/21121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regimbeau.eu\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regimbeau.eu\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regimbeau.eu\/ja\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/regimbeau.eu\/ja\/wp-json\/wp\/v2\/comments?post=21121"}],"version-history":[{"count":0,"href":"https:\/\/regimbeau.eu\/ja\/wp-json\/wp\/v2\/posts\/21121\/revisions"}],"wp:attachment":[{"href":"https:\/\/regimbeau.eu\/ja\/wp-json\/wp\/v2\/media?parent=21121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regimbeau.eu\/ja\/wp-json\/wp\/v2\/categories?post=21121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regimbeau.eu\/ja\/wp-json\/wp\/v2\/tags?post=21121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}